Evidence map›Paper›PMID 40111686›Full record

ReviewAdvances in experimental medicine and biology2025

Link Between Oral and Gut Microbiomes: The Oral-Gut Axis.

Ana Paula Vieira Colombo, Talita Gomes Baêta Lourenço, Adriana Miranda de Oliveira, André Luiz Amorim da Costa

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Role of Innate Oral Immunity and the Salivary Fluid in Inflammatory Bowel Disease.Cellular and molecular gastroenterology and hepatology · 2026
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ana Paula Vieira ColomboOral Microbiology Laboratory, Institute of Microbiology Paulo de Góes, UFRJ, Rio de Janeiro, Brazil. apcolombo@micro.ufrj.br.ORCID https://orcid.org/0000-0002-2061-1840
Talita Gomes Baêta LourençoOral Microbiology Laboratory, Institute of Microbiology Paulo de Góes, UFRJ, Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0003-0966-3620
Adriana Miranda de OliveiraOral Microbiology Laboratory, Institute of Microbiology Paulo de Góes, UFRJ, Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0001-9096-9576
André Luiz Amorim da CostaOral Microbiology Laboratory, Institute of Microbiology Paulo de Góes, UFRJ, Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0002-2170-7940

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decades, groundbreaking research on the human microbiome has changed our reductionist conception of the etiology and pathogenesis of several chronic diseases. As a result, we have come to appreciate the significance of a balanced microbiome in maintaining human health. In this context, the upper and lower gastrointestinal tracts (GITs) comprise the most abundant and diverse microbiotas of the human body. In addition to its diversity, functional redundancy, and temporal stability, a healthy GIT microbiome is characterized by its body site specificity. In fact, current evidence has indicated that the translocation of oral species to the gut environment through the oral-gut axis is increased in an array of illnesses, including chronic inflammatory and metabolic diseases, neurological disorders, and cancer. Oral pathogens have also been shown to promote gut dysbiosis and systemic inflammation in animal models. Yet, some level of overlapping between oral and gut microbiomes may occur without disruption of these microbial communities and loss of site specificity. The uniqueness of each host-microbiome entity may hinder our ability to define a "universal" normal GIT microbiome. Despite that, this chapter summarizes the predominant health-related taxa along the human GIT, as well as their role in the physiology and immunity of the digestive system. Some mechanisms that may lead to disturbances and relevant shifts in the oral and gut microbiomes of major inflammatory chronic diseases are also pointed out. Lastly, oral-fecal microbial signatures are presented as potential biomarkers for several oral and systemic disorders. The recognition of such symbiotic/dysbiotic microbial profiles may provide insights into the development of more accurate early diagnosis and therapeutic ecological approaches to restore the balance of the GIT microbiome.

Indexed as

Gastrointestinal MicrobiomeGastrointestinal TractMouthAnimalsDysbiosisHumansGastrointestinal tract (GIT)Gut microbiomeInflammatory chronic diseasesMucosal immunityOral diseasesOral microbiomeSymbiosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.